SPECTRAMED INC <SPMD.O> 3RD QTR NET Shr profit seven cts vs n/a Net profit 587,000 vs profit 3,231,000 Sales 18.5 mln vs 18.7 mln Nine Mths Shr loss 39 ct s vs n/a Net loss 2,368,000 vs protit 7,165,000 Sales 55.4 mln vs 54.2 mln Note: Current nine month figures include extraordinary loss of 1.2 mln dlrs, or 17 cts per share, resulting from costs associated with restructuring. Prior quarter and nine month per share figures not applicable because company began operations in October, 1986 with the acquisition of Gould Inc's <GLD> medical products group.